| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3519ea242d97a904badff9271f63de45 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-497
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-18 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-497
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 |
| filingDate |
2016-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aac881b69cc508ad9cd33270da4de1e0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_da4afa7a7ba0cd2047b8d32a666a71c6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_58cbad39536f88c5b5d9241bf1169a77
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d18f137b4e8f0634b13156ef47eea75d |
| publicationDate |
2017-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2017135540-A1 |
| titleOfInvention |
Tablet containing teneligliptin and sulfonylurea-based drug |
| abstract |
The present invention relates to a complex tablet containing teneligliptin or a salt thereof and a sulfonylurea-based drug, wherein the complex tablet is prepared by mixing and tableting teneligliptin grains containing teneligliptin or a salt thereof and sulfonylurea-based grains containing a sulfonylurea-based drug. Preferably, both of the teneligliptin grains and sulfonylurea-based grains according to the present invention contain mannitol as a diluent. The complex tablet according to the present invention can effectively treat diabetic diseases by different mechanisms of teneligliptin and sulfonylurea, retains excellent stability due to a minimized interaction between drugs, and has excellent release patterns and absorption patterns. In addition, the complex tablet according to the present invention can reduce the absorption deviation between individuals and within individuals due to a reduced release deviation thereof. |
| priorityDate |
2016-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |